Tag: Europe
-
Novo Nordisk, Foundation to Partner on Type 1 Diabetes
JDRF, a foundation supporting research on type 1 diabetes, and the Danish pharmaceutical company Novo Nordisk will partner on studies of the autoimmune process that plays a key role in type 1 diabetes. Financial details of the collaboration were not disclosed. Type 1 diabetes is sometimes called insulin-dependent, immune-mediated, or juvenile-onset diabetes, although it can…
-
Trial Shows Long-Term Benefit of Multiple Sclerosis Drug
The drug company Novartis today released results of a clinical trial that shows patients with multiple sclerosis taking its drug fingolimod — marketed under the name Gilenya — had fewer relapses and lower brain volume loss, including among patients who switched from a competing drug. The findings are expected to be delivered today at a…
-
Robotic-Guided Brain Surgery Performed
Mazor Robotics Ltd. in Caesarea, Israel says it completed three robot-guided brain surgical procedures with its technology. The nature of the procedures was not disclosed. The procedures were performed by neurosurgeons In-Se Kim and Robert Schönmayr at Horst Schmidt Kliniken in Wiesbaden, Germany. Mazor Robotics is a developer of robotics for spinal surgery, often involving…
-
High-Energy Infrared Beams Adapted for Tabletop X-Ray Device
Physicists from University of Colorado at Boulder, with colleagues from the U.S., Austria, and Spain, have developed an X-ray system that captures concentrated infrared beams, in a compact device that can fit on a lab table. The team led by Colorado researchers Henry Kapteyn and Margaret Murnane published their findings in the 8 June issue…
-
IVF Assessment Company Lands $18M in Venture Capital
Auxogyn Inc., in Menlo Park, California, a developer of viability tests of embryos during in vitro fertilization (IVF) procedures, has raised $18 million in series B venture funds, the second round of financing after initial start-up. The financing was led by new investor SR One — the corporate venture capital arm of GlaxoSmithKline — and…
-
Low-Dose, High-Rez CT Scanning Technique Developed
Researchers from France, Germany, and Switzerland have devised an X-ray imaging technique that can improve the contrast of computed tomography (CT) scans while reducing the radiation dose of those scans. The results of the team led by Irene Zanette of the European Synchrotron Radiation Facility in Grenoble, France will be published this week in the…
-
Solar Developer Secures $70 Million in Venture Financing
Nanosolar Inc. in San Jose, California says it has raised $70 million in new capital for further research and development and to expand production. This later-stage investment round includes current and new investors OnPoint Technologies, Inc., Mohr Davidow Ventures, Ohana Holdings LLC, and Family Offices. In February, the company secured $20 million in venture financing…
-
International Consortium Studies Corn Genome
A collaboration of genetic and agricultural scientists from the U.S., Mexico, France, Kenya, and China have conducted a comprehensive analysis of the corn genome. The team, led by researchers from Cornell University and the USDA’s Agricultural Research Service, and funded by USDA and National Science Foundation, published their findings online in the journal Nature Genetics…
-
Company, University Lab Design Thermal Solar Collector
An engineering company in Madrid, Spain, working with a research group at Universidad Carlos III de Madrid (UC3M), has designed a new central receiver for a solar thermal energy plant recently installed in Spain. Sun to Market is an engineering and IT services company in the solar energy sector that collaborated with UC3M’s Energy Systems…
-
Bristol-Myers Squibb Sponsoring Cancer Research Network
Bristol-Myers Squibb Co., a pharmaceutical company in Princeton, New Jersey, has a new collaboration with academic researchers that aims to better understand the science of immuno-oncology, the harnessing of the body’s immune system to fight cancer. The network includes researchers from 10 universities and research institutes in the U.S. and Europe. The company says its…